MoneyWorks4Me

Sigachi Industries - Quaterly Results

30 Jan 2023 Evaluate
Revenue showed a marginal decline at Rs. 653.25 millions. For the quarter ended December 2022, as compared to corresponding quarter of last year.A meek growth of 0.21% was reported for the quarter ended December 2022 to Rs. 93.23  millions from Rs. 93.03 millions.The company reported a good operating profit of 147.24 millions compared to 127.27 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 653.25 664.97 -1.76 2142.44 1785.35 20.00 2494.05 1879.42 32.70
Other Income 12.89 5.25 145.52 51.22 9.01 468.48 26.30 32.55 -19.20
PBIDT 147.24 127.27 15.69 469.32 380.88 23.22 530.26 405.89 30.64
Interest 12.03 2.61 360.92 28.75 6.81 322.17 11.55 11.59 -0.35
PBDT 135.21 124.66 8.46 440.57 374.07 17.78 518.71 394.30 31.55
Depreciation 17.77 7.44 138.84 46.47 21.05 120.76 29.05 23.11 25.70
PBT 117.44 117.22 0.19 394.10 353.02 11.64 489.66 371.19 31.92
TAX 24.21 24.19 0.08 72.82 77.00 -5.43 109.37 80.60 35.69
Deferred Tax 0.80 2.99 -73.24 -8.12 5.78 -240.48 10.53 14.94 -29.52
PAT 93.23 93.03 0.21 321.28 276.02 16.40 380.29 290.59 30.87
Equity 307.43 307.43 0.00 307.43 307.43 0.00 307.43 76.83 300.14
PBIDTM(%) 22.54 19.14 17.77 21.91 21.33 2.68 21.26 21.60 -1.55
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..